Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Nutex Health (NUTX) Cost of Revenue (2017 - 2025)

Nutex Health's Cost of Revenue history spans 16 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 122.54% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $17.2 million, up 12.8%, while the annual FY2025 figure was $17.2 million, 12.8% up from the prior year.
  • Cost of Revenue for Q4 2025 was $5.3 million at Nutex Health, up from $3.3 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $5.3 million in Q1 2024 and bottomed at $6704.0 in Q2 2021.
  • The 5-year median for Cost of Revenue is $3.4 million (2023), against an average of $3.4 million.
  • The largest annual shift saw Cost of Revenue tumbled 87.27% in 2021 before it surged 38407.64% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $2.6 million in 2021, then grew by 7.43% to $2.8 million in 2022, then increased by 21.89% to $3.4 million in 2023, then decreased by 29.73% to $2.4 million in 2024, then skyrocketed by 122.54% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Cost of Revenue are $5.3 million (Q4 2025), $3.3 million (Q3 2025), and $4.8 million (Q2 2025).